Iovance Biotherapeutics (IOVA) Tops Q1 EPS by 7c

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Iovance Biotherapeutics (IOVA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Amneal gets FDA approval for lanreotide injection, launches immediately
• Lumentum shares rise on analyst upgrades, AI demand outlook